{"transactions":[{"id":4628723,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-10-02T23:00:04.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":25457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 524,030 restricted stock units."}],"balance_after":753226,"source":{"system":"sec-edgar","filing":"0001193125-26-412727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916619/000119312526412727/ownership.xml","form_type":"4"}},{"id":677560,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":4.3392,"value":47731.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3097 to $4.3489 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7404383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":677559,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.3495,"value":21747.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7393383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":677558,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":39944,"price":4.4356,"value":177175.6064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3198 to $4.5048 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7388383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":689378,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-08-12T22:00:03.000Z","date":"2026-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 463,167 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":679863,"source":{"system":"sec-edgar","filing":"0001193125-26-347275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526347275/ownership.xml","form_type":"4"}},{"id":689287,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T21:30:04.000Z","date":"2026-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":37102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 717,604 restricted stock units."}],"balance_after":914900,"source":{"system":"sec-edgar","filing":"0001193125-26-347223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526347223/ownership.xml","form_type":"4"}},{"id":688882,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-08-12T21:30:03.000Z","date":"2026-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":16253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 590,697 restricted stock units."}],"balance_after":778683,"source":{"system":"sec-edgar","filing":"0001193125-26-347222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526347222/ownership.xml","form_type":"4"}},{"id":740126,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T13:26:46.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":9891,"price":4.0423,"value":39982.3893,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 11, 2026 as a total of 22,887 shares purchased when in fact 9,891 shares of the Issuer's common stock were purchased."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 542,784 restricted stock units."}],"balance_after":7348439,"source":{"system":"sec-edgar","filing":"0001193125-26-268606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526268606/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-11"}},{"id":740125,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T13:26:46.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":14715,"price":4.024,"value":59213.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 10, 2026 as a total of 29,430 shares purchased when in fact 14,715 shares of the Issuer's common stock were purchased."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 542,784 restricted stock units."}],"balance_after":7338548,"source":{"system":"sec-edgar","filing":"0001193125-26-268606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526268606/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-11"}},{"id":741848,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:52:42.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":22887,"price":4.0434,"value":92541.2958,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7376150,"source":{"system":"sec-edgar","filing":"0001193125-26-267800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526267800/ownership.xml","form_type":"4"}},{"id":741847,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:52:42.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":29430,"price":4.024,"value":118426.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7353263,"source":{"system":"sec-edgar","filing":"0001193125-26-267800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526267800/ownership.xml","form_type":"4"}},{"id":757192,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:38:10.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.5583,"value":177915.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.5100 to $3.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7323833,"source":{"system":"sec-edgar","filing":"0001193125-26-251587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526251587/ownership.xml","form_type":"4"}},{"id":760331,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-28","kind":"purchase","planned":false,"acquired":true,"shares":61202,"price":3.0199,"value":184823.9198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.8233 to $3.1150 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7273833,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":760330,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":49810,"price":2.8747,"value":143188.807,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7976 to $2.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7212631,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":760329,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":4508,"price":2.7897,"value":12575.9676,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7600 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7162821,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":771650,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:11.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":204056,"source":{"system":"sec-edgar","filing":"0001193125-26-231466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000119312526231466/ownership.xml","form_type":"4"}},{"id":771441,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:08.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":93949,"source":{"system":"sec-edgar","filing":"0001193125-26-231464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000119312526231464/ownership.xml","form_type":"4"}},{"id":771952,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:07.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":74593,"source":{"system":"sec-edgar","filing":"0001193125-26-231462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000119312526231462/ownership.xml","form_type":"4"}},{"id":771181,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45897,"kind":"person","name":"Jain Deepti","position":1,"cik":"0001840203","reported_name":"Jain Deepti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:06.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":100243,"source":{"system":"sec-edgar","filing":"0001193125-26-231463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526231463/ownership.xml","form_type":"4"}},{"id":771494,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45945,"kind":"person","name":"HAMILTON LAWRENCE W","position":1,"cik":"0001326586","reported_name":"HAMILTON LAWRENCE W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:05.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":74056,"source":{"system":"sec-edgar","filing":"0001193125-26-231461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326586/000119312526231461/ownership.xml","form_type":"4"}},{"id":772382,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":46017,"kind":"person","name":"Hanna Betsy","position":1,"cik":"0001885957","reported_name":"Hanna Betsy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:02.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":75243,"source":{"system":"sec-edgar","filing":"0001193125-26-231459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885957/000119312526231459/ownership.xml","form_type":"4"}},{"id":779368,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":61750,"price":2.6153,"value":161494.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.4950 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7158313,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":779367,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-13","kind":"purchase","planned":false,"acquired":true,"shares":49013,"price":2.4592,"value":120532.7696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.3850 to $2.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7096563,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":779366,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-12","kind":"purchase","planned":false,"acquired":true,"shares":43000,"price":2.1739,"value":93477.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $1.9100 to $2.2800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7047550,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":804505,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-21T01:00:03.000Z","date":"2026-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":11547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 786,691 restricted stock units."}],"balance_after":952002,"source":{"system":"sec-edgar","filing":"0001193125-26-164654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526164654/ownership.xml","form_type":"4"}},{"id":816495,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-04T01:00:04.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs were earned upon the Compensation Committee's certification of accomplishment of a performance goal and will vest 25% on April 15, 2026 and 25% on each February 15 of 2027, 2028, and 2029, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 811,691 restricted stock units."}],"balance_after":963549,"source":{"system":"sec-edgar","filing":"0001193125-26-142647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526142647/ownership.xml","form_type":"4"}},{"id":848172,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:07.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 633,877 restricted stock units."}],"balance_after":794936,"source":{"system":"sec-edgar","filing":"0001193125-26-102764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526102764/ownership.xml","form_type":"4"}},{"id":848171,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:07.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 640,752 restricted stock units."}],"balance_after":796611,"source":{"system":"sec-edgar","filing":"0001193125-26-102764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526102764/ownership.xml","form_type":"4"}},{"id":848894,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:06.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 503,917 restricted stock units."}],"balance_after":704677,"source":{"system":"sec-edgar","filing":"0001193125-26-102763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526102763/ownership.xml","form_type":"4"}},{"id":848893,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:06.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 509,648 restricted stock units."}],"balance_after":706073,"source":{"system":"sec-edgar","filing":"0001193125-26-102763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526102763/ownership.xml","form_type":"4"}},{"id":848887,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:04.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7004550,"source":{"system":"sec-edgar","filing":"0001193125-26-102762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526102762/ownership.xml","form_type":"4"}},{"id":848886,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:04.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 563,403 restricted stock units."}],"balance_after":7009571,"source":{"system":"sec-edgar","filing":"0001193125-26-102762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526102762/ownership.xml","form_type":"4"}},{"id":848713,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:03.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 711,691 restricted stock units."}],"balance_after":863549,"source":{"system":"sec-edgar","filing":"0001193125-26-102761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526102761/ownership.xml","form_type":"4"}},{"id":848712,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:03.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 723,147 restricted stock units."}],"balance_after":867244,"source":{"system":"sec-edgar","filing":"0001193125-26-102761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526102761/ownership.xml","form_type":"4"}},{"id":910124,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T02:00:03.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":16875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021."}],"balance_after":0,"derivative":{"exercise_price":1.05,"exercise_date":"2021-01-30","expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":16875},"source":{"system":"sec-edgar","filing":"0001193125-26-047313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526047313/ownership.xml","form_type":"4"}},{"id":910123,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-02-12T02:00:03.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":16875,"price":1.05,"value":17718.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 511, 291 restricted stock units."}],"balance_after":706474,"source":{"system":"sec-edgar","filing":"0001193125-26-047313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526047313/ownership.xml","form_type":"4"}},{"id":931966,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:08.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 641,470 restricted stock units."}],"balance_after":796786,"source":{"system":"sec-edgar","filing":"0001193125-26-021452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526021452/ownership.xml","form_type":"4"}},{"id":931965,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:08.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":9451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 378,970 restricted stock units."}],"balance_after":534286,"source":{"system":"sec-edgar","filing":"0001193125-26-021452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526021452/ownership.xml","form_type":"4"}},{"id":932340,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:06.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 726,134 restricted stock units."}],"balance_after":868208,"source":{"system":"sec-edgar","filing":"0001193125-26-021451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526021451/ownership.xml","form_type":"4"}},{"id":932339,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:06.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":17037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 351,134 restricted stock units."}],"balance_after":493208,"source":{"system":"sec-edgar","filing":"0001193125-26-021451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526021451/ownership.xml","form_type":"4"}},{"id":932445,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":53500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":0.72,"exercise_date":"2020-01-26","expiration_date":"2026-01-26","underlying":"Common Stock","underlying_shares":53500},"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":932444,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 511,291 restricted stock units"}],"balance_after":689599,"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":932443,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:05.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":53500,"price":0.72,"value":38520.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 283,948 restricted stock units."}],"balance_after":427099,"source":{"system":"sec-edgar","filing":"0001193125-26-021450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312526021450/ownership.xml","form_type":"4"}},{"id":932447,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:03.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 571,871 restricted stock units."}],"balance_after":7011633,"source":{"system":"sec-edgar","filing":"0001193125-26-021449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526021449/ownership.xml","form_type":"4"}},{"id":932446,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:03.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":14254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 321,871 restricted stock units."}],"balance_after":6761633,"source":{"system":"sec-edgar","filing":"0001193125-26-021449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526021449/ownership.xml","form_type":"4"}},{"id":932536,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":68923,"kind":"person","name":"Guglielmino Gaetano","position":1,"cik":"0002047624","reported_name":"Guglielmino Gaetano","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:30:09.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 422,250 restricted stock units."}],"balance_after":490901,"source":{"system":"sec-edgar","filing":"0001193125-26-021453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047624/000119312526021453/ownership.xml","form_type":"4"}},{"id":940088,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-14T02:30:06.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":8719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 398,009 restricted stock units."}],"balance_after":510245,"source":{"system":"sec-edgar","filing":"0001193125-26-012082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000119312526012082/ownership.xml","form_type":"4"}},{"id":939902,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2026-01-14T02:30:04.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 410,845 restricted stock units."}],"balance_after":543737,"source":{"system":"sec-edgar","filing":"0001193125-26-012081","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312526012081/ownership.xml","form_type":"4"}},{"id":940142,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-14T02:30:03.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":13219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 363,867 restricted stock units."}],"balance_after":6775887,"source":{"system":"sec-edgar","filing":"0001193125-26-012080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526012080/ownership.xml","form_type":"4"}},{"id":981979,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":68923,"kind":"person","name":"Guglielmino Gaetano","position":1,"cik":"0002047624","reported_name":"Guglielmino Guy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-03T21:00:02.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 272,250 restricted stock units."}],"balance_after":340901,"source":{"system":"sec-edgar","filing":"0001193125-25-307269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047624/000119312525307269/ownership.xml","form_type":"4"}},{"id":981978,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":68923,"kind":"person","name":"Guglielmino Gaetano","position":1,"cik":"0002047624","reported_name":"Guglielmino Guy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-03T21:00:02.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 280,500 restricted stock units."}],"balance_after":342910,"source":{"system":"sec-edgar","filing":"0001193125-25-307269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047624/000119312525307269/ownership.xml","form_type":"4"}},{"id":1012640,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-10-28T21:00:07.000Z","date":"2025-10-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 283,948 restricted stock units."}],"balance_after":373599,"source":{"system":"sec-edgar","filing":"0001193125-25-253801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000119312525253801/ownership.xml","form_type":"4"}},{"id":1012427,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-10-28T21:00:06.000Z","date":"2025-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,170 restricted stock units."}],"balance_after":548281,"source":{"system":"sec-edgar","filing":"0001193125-25-253800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525253800/ownership.xml","form_type":"4"}},{"id":1026487,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-10-03T01:30:04.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 428,670 restricted stock units."}],"balance_after":549265,"source":{"system":"sec-edgar","filing":"0001193125-25-228960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525228960/ownership.xml","form_type":"4"}},{"id":1026486,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-10-03T01:30:04.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":16234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 429,670 restricted stock units."}],"balance_after":549915,"source":{"system":"sec-edgar","filing":"0001193125-25-228960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525228960/ownership.xml","form_type":"4"}},{"id":1068580,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-08-13T01:30:10.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 480,103 restricted stock units."}],"balance_after":566149,"source":{"system":"sec-edgar","filing":"0000950170-25-107557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025107557/ownership.xml","form_type":"4"}},{"id":1068944,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-13T01:30:09.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":22212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 421,228 restricted stock units."}],"balance_after":518964,"source":{"system":"sec-edgar","filing":"0000950170-25-107556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000095017025107556/ownership.xml","form_type":"4"}},{"id":1069044,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-08-13T01:30:07.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 284,798 restricted stock units."}],"balance_after":373807,"source":{"system":"sec-edgar","filing":"0000950170-25-107555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025107555/ownership.xml","form_type":"4"}},{"id":1068579,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":76633,"kind":"person","name":"Berutti Aaron","position":1,"cik":"0001871334","reported_name":"Berutti Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales"}}],"security":"Common Stock","published_at":"2025-08-13T01:30:06.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":4907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 181,955 restricted stock units."}],"balance_after":205092,"source":{"system":"sec-edgar","filing":"0000950170-25-107554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025107554/ownership.xml","form_type":"4"}},{"id":1083456,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-22T21:00:09.000Z","date":"2025-07-18","kind":"exercise","planned":false,"acquired":false,"shares":33437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019."}],"balance_after":0,"derivative":{"exercise_price":0.7178,"exercise_date":"2019-07-28","expiration_date":"2025-07-28","underlying":"Common Stock","underlying_shares":33437},"source":{"system":"sec-edgar","filing":"0000950170-25-097601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025097601/ownership.xml","form_type":"4"}},{"id":1083455,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-07-22T21:00:09.000Z","date":"2025-07-18","kind":"exercise","planned":false,"acquired":true,"shares":33437,"price":0.7178,"value":24001.0786,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 325,098 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":383621,"source":{"system":"sec-edgar","filing":"0000950170-25-097601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025097601/ownership.xml","form_type":"4"}},{"id":1138618,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45897,"kind":"person","name":"Jain Deepti","position":1,"cik":"0001840203","reported_name":"Jain Deepti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:14.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":70243,"source":{"system":"sec-edgar","filing":"0000950170-25-075894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025075894/ownership.xml","form_type":"4"}},{"id":1138937,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:13.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,861 restricted stock units."}],"balance_after":44593,"source":{"system":"sec-edgar","filing":"0000950170-25-075893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000095017025075893/ownership.xml","form_type":"4"}},{"id":1138800,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45945,"kind":"person","name":"HAMILTON LAWRENCE W","position":1,"cik":"0001326586","reported_name":"HAMILTON LAWRENCE W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:11.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":44056,"source":{"system":"sec-edgar","filing":"0000950170-25-075892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326586/000095017025075892/ownership.xml","form_type":"4"}},{"id":1138770,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:09.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,861 restricted stock units."}],"balance_after":63949,"source":{"system":"sec-edgar","filing":"0000950170-25-075891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000095017025075891/ownership.xml","form_type":"4"}},{"id":1139165,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":46017,"kind":"person","name":"Hanna Betsy","position":1,"cik":"0001885957","reported_name":"Hanna Betsy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:07.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":45243,"source":{"system":"sec-edgar","filing":"0000950170-25-075890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885957/000095017025075890/ownership.xml","form_type":"4"}},{"id":1138848,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:04.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":174056,"source":{"system":"sec-edgar","filing":"0000950170-25-075888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000095017025075888/ownership.xml","form_type":"4"}},{"id":1138825,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":79463,"kind":"person","name":"MOTT RICHARD W","position":1,"cik":"0001210226","reported_name":"MOTT RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T17:30:05.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":1096861,"source":{"system":"sec-edgar","filing":"0000950170-25-075889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210226/000095017025075889/ownership.xml","form_type":"4"}},{"id":1151950,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-05-12T21:30:05.000Z","date":"2025-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1894,"price":7.54,"value":14280.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 523,283 restricted stock units."}],"balance_after":576664,"source":{"system":"sec-edgar","filing":"0000950170-25-069492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025069492/ownership.xml","form_type":"4"}},{"id":1151949,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-05-12T21:30:05.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs vested upon the accomplishment of a performance goal related to enforcement of the Company's intellectual property rights."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 523,283 restricted stock units."}],"balance_after":578558,"source":{"system":"sec-edgar","filing":"0000950170-25-069492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025069492/ownership.xml","form_type":"4"}},{"id":1197242,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021."}],"balance_after":16875,"derivative":{"exercise_price":1.05,"exercise_date":"2021-01-30","expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1197241,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":7.9692,"value":398460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.8800 to $8.0900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":364081,"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1197240,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-20T01:30:04.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.05,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":414081,"source":{"system":"sec-edgar","filing":"0000950170-25-042291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025042291/ownership.xml","form_type":"4"}},{"id":1211550,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":76633,"kind":"person","name":"Berutti Aaron","position":1,"cik":"0001871334","reported_name":"Berutti Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:14.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 202,105 restricted stock units"}],"balance_after":209999,"source":{"system":"sec-edgar","filing":"0000950170-25-037575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025037575/ownership.xml","form_type":"4"}},{"id":1211549,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":76633,"kind":"person","name":"Berutti Aaron","position":1,"cik":"0001871334","reported_name":"Berutti Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:14.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 209,555 restricted stock units"}],"balance_after":211814,"source":{"system":"sec-edgar","filing":"0000950170-25-037575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025037575/ownership.xml","form_type":"4"}},{"id":1212508,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:13.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 408,448 restricted stock units"}],"balance_after":6789106,"source":{"system":"sec-edgar","filing":"0000950170-25-037574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025037574/ownership.xml","form_type":"4"}},{"id":1212507,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:13.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 429,067 restricted stock units"}],"balance_after":6794127,"source":{"system":"sec-edgar","filing":"0000950170-25-037574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025037574/ownership.xml","form_type":"4"}},{"id":1212510,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:11.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 325,098 restricted stock units."}],"balance_after":364081,"source":{"system":"sec-edgar","filing":"0000950170-25-037572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025037572/ownership.xml","form_type":"4"}},{"id":1212509,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:11.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 330,829 restricted stock units."}],"balance_after":365477,"source":{"system":"sec-edgar","filing":"0000950170-25-037572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025037572/ownership.xml","form_type":"4"}},{"id":1211548,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:07.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 523,283 restricted stock units."}],"balance_after":570783,"source":{"system":"sec-edgar","filing":"0000950170-25-037569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025037569/ownership.xml","form_type":"4"}},{"id":1211547,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:07.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 530,158 restricted stock units."}],"balance_after":572458,"source":{"system":"sec-edgar","filing":"0000950170-25-037569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025037569/ownership.xml","form_type":"4"}},{"id":1212308,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:03.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 490,315 restricted stock units."}],"balance_after":541176,"source":{"system":"sec-edgar","filing":"0000950170-25-037566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000095017025037566/ownership.xml","form_type":"4"}},{"id":1212307,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:03.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 501,771 restricted stock units."}],"balance_after":544860,"source":{"system":"sec-edgar","filing":"0000950170-25-037566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000095017025037566/ownership.xml","form_type":"4"}},{"id":1229359,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:30:03.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":8.7344,"value":524064.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $8.3150 to $8.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 437,536 restricted stock units"}],"balance_after":6796190,"source":{"system":"sec-edgar","filing":"0000950170-25-032626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025032626/ownership.xml","form_type":"4"}},{"id":1295354,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":76633,"kind":"person","name":"Berutti Aaron","position":1,"cik":"0001871334","reported_name":"Berutti Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:07.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 212,542 restricted stock units."}],"balance_after":212542,"source":{"system":"sec-edgar","filing":"0000950170-25-008974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025008974/ownership.xml","form_type":"4"}},{"id":1295674,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:06.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":140625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 332,473 restricted stock units."}],"balance_after":365878,"source":{"system":"sec-edgar","filing":"0000950170-25-008973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025008973/ownership.xml","form_type":"4"}},{"id":1295675,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:04.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 437,536 restricted stock units"}],"balance_after":6736190,"source":{"system":"sec-edgar","filing":"0000950170-25-008971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025008971/ownership.xml","form_type":"4"}},{"id":1295353,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:04.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 530,877 restricted stock units"}],"balance_after":572634,"source":{"system":"sec-edgar","filing":"0000950170-25-008972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025008972/ownership.xml","form_type":"4"}},{"id":1295635,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:03.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include 504,758 restricted stock units and reflect that the Reporting Person no longer has any indirect ownership through dependent children."}],"balance_after":546821,"source":{"system":"sec-edgar","filing":"0000950170-25-008970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000095017025008970/ownership.xml","form_type":"4"}},{"id":1303489,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24133,"kind":"person","name":"Hair Mark","position":1,"cik":"0001725070","reported_name":"Hair Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:11.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":8594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 326,548 restricted stock units."}],"balance_after":359321,"source":{"system":"sec-edgar","filing":"0000950170-25-005582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725070/000095017025005582/ownership.xml","form_type":"4"}},{"id":1303567,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24167,"kind":"person","name":"Scanlan Sean F.","position":1,"cik":"0001856371","reported_name":"Scanlan Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:08.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 198,078 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 20,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order."}],"balance_after":225253,"source":{"system":"sec-edgar","filing":"0000950170-25-005580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856371/000095017025005580/ownership.xml","form_type":"4"}},{"id":1303167,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:07.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 403,327 restricted stock units."}],"balance_after":445134,"source":{"system":"sec-edgar","filing":"0000950170-25-005579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025005579/ownership.xml","form_type":"4"}},{"id":1303168,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":76633,"kind":"person","name":"Berutti Aaron","position":1,"cik":"0001871334","reported_name":"Berutti Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:05.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 145,454 restricted stock units"}],"balance_after":160970,"source":{"system":"sec-edgar","filing":"0000950170-25-005578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017025005578/ownership.xml","form_type":"4"}},{"id":1303568,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:04.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 151,882 restricted stock units"}],"balance_after":6511190,"source":{"system":"sec-edgar","filing":"0000950170-25-005577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025005577/ownership.xml","form_type":"4"}},{"id":1341863,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":68923,"kind":"person","name":"Guglielmino Gaetano","position":1,"cik":"0002047624","reported_name":"Guglielmino Guy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T16:30:13.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in four equal annual installments on the first, second, third and fourth anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date. These RSUs represented a portion of the executive's signing bonus which was granted in equity rather than in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 363,000 RSUs."}],"balance_after":363000,"source":{"system":"sec-edgar","filing":"0000950170-24-133720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047624/000095017024133720/ownership.xml","form_type":"4"}},{"id":1341862,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":68923,"kind":"person","name":"Guglielmino Gaetano","position":1,"cik":"0002047624","reported_name":"Guglielmino Guy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T16:30:13.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in four equal annual installments on the first, second, third and fourth anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"includes 330,000 RSUs."}],"balance_after":330000,"source":{"system":"sec-edgar","filing":"0000950170-24-133720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047624/000095017024133720/ownership.xml","form_type":"4"}},{"id":1366193,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2024-11-13T23:19:11.000Z","date":"2024-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3787,"price":8.29,"value":31394.23,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 418,702 restricted stock units."}],"balance_after":449678,"source":{"system":"sec-edgar","filing":"0000950170-24-126551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017024126551/ownership.xml","form_type":"4"}},{"id":1366192,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2024-11-13T23:19:11.000Z","date":"2024-11-11","kind":"grant","planned":false,"acquired":true,"shares":15550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units (\"PSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs vested upon the accomplishment of a performance goal related to enforcement of the Company's intellectual property rights."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 418,702 restricted stock units."}],"balance_after":453654,"source":{"system":"sec-edgar","filing":"0000950170-24-126551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017024126551/ownership.xml","form_type":"4"}},{"id":1393687,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":24014,"kind":"person","name":"Elder Scot Michael","position":1,"cik":"0001916619","reported_name":"Elder Scot Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legl & Comp Off, CorpSec"}}],"security":"Common Stock","published_at":"2024-10-02T23:30:03.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 433,637 restricted stock units."}],"balance_after":437915,"source":{"system":"sec-edgar","filing":"0000950170-24-111853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017024111853/ownership.xml","form_type":"4"}},{"id":1405330,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T21:17:19.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":5.3126,"value":265630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.0550 to $5.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,464 restricted stock units"}],"balance_after":6523095,"source":{"system":"sec-edgar","filing":"0000950170-24-107401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024107401/ownership.xml","form_type":"4"}}],"next_cursor":"2024-09-17T21:17:19.000000Z,1405330"}